(0 items) Help
Home → Medicine → Hematology
Edited by Matthew B. Yurgelun, MD and Douglas A. Rubinson, MD, PhD
240 pagesCopyright 2022$116.99, Online Product, Reference
A title in the The Clinics: Internal Medicine Series.
Availability:This title is in stock.
Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more.
Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Edited by Matthew B. Yurgelun, MD, Assistant Professor, Medicine, Harvard Medical School, Assistant Professor, Medical Oncology, Dana-Farber Cancer Institute
and Douglas A. Rubinson, MD, PhD, Assistant Professor, Medicine, Dana-Farber Cancer Institute and Harvard Medical School